A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Pharmacokinetics and Efficacy of Intravenous Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor

Trial Profile

A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Pharmacokinetics and Efficacy of Intravenous Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jun 2014

At a glance

  • Drugs Serelaxin (Primary)
  • Indications Labour disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Apr 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
    • 29 Sep 2006 Status change
    • 24 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top